BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Staging
34 results:

  • 1. Disulfideptosis-associated lncRNAs reveal features of prognostic, immune escape, tumor mutation, and tumor malignant progression in renal clear cell carcinoma.
    Li X; Deng X; Liu T; Zhang W; Tao J
    Aging (Albany NY); 2024 Feb; 16(4):3280-3301. PubMed ID: 38334964
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Survival Outcome of Urinary Diversion in Advanced Cervical Cancer Patients with Hydronephrosis.
    Dhani FK; Daryanto B; Seputra KP
    Asian Pac J Cancer Prev; 2023 Aug; 24(8):2641-2646. PubMed ID: 37642049
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Web-based nomogram and risk stratification system constructed for predicting the overall survival of older adults with primary kidney cancer after surgical resection.
    Jiang L; Wang C; Tong Y; Jiang J; Zhao D
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11873-11889. PubMed ID: 37410141
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Multimodal recurrence scoring system for prediction of clear cell renal cell carcinoma outcome: a discovery and validation study.
    Gui CP; Chen YH; Zhao HW; Cao JZ; Liu TJ; Xiong SW; Yu YF; Liao B; Cao Y; Li JY; Huang KB; Han H; Zhang ZL; Chen WF; Jiang ZY; Gao Y; Han GP; Tang Q; Ouyang K; Qu GM; Wu JT; Guo JP; Li CX; Li PX; Liu ZP; Hsieh JT; Cai MY; Li XS; Wei JH; Luo JH
    Lancet Digit Health; 2023 Aug; 5(8):e515-e524. PubMed ID: 37393162
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prediction values of tertiary lymphoid structures in the prognosis of patients with left- and right-sided colon cancer: a multicenter propensity score-matched study.
    Mao Y; Wang X; Xi L; Dong M; Song P; Miao J; Lu C; Sun S; Li Q; Yu C; Shen X
    Int J Surg; 2023 Aug; 109(8):2344-2358. PubMed ID: 37247038
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prognostic nomogram for overall survival in upper urinary tract urothelial carcinoma (UTUC) patients treated with chemotherapy: a SEER-based retrospective cohort study.
    Tian C; Liu J; An L; Hong Y; Xu Q
    BMC Urol; 2023 Jan; 23(1):2. PubMed ID: 36609283
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prediction of pathological staging and grading of renal clear cell carcinoma based on deep learning algorithms.
    Wen-Zhi G; Tai T; Zhixin F; Huanyu L; Yanqing G; Yuexian G; Xuesong L
    J Int Med Res; 2022 Nov; 50(11):3000605221135163. PubMed ID: 36396624
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification of Survival Risk and Immune-Related Characteristics of kidney Renal Clear Cell Carcinoma.
    Wu X; Liang Y; Chen X; Long X; Xu W; Liu L; Wang B; Zou X
    J Immunol Res; 2022; 2022():6149369. PubMed ID: 35832648
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Development and Validation of a Competitive Risk Model in Elderly Patients With Chromophobe Cell Renal Carcinoma: A Population-Based Study.
    Wang J; Zhanghuang C; Tan X; Mi T; Liu J; Jin L; Li M; Zhang Z; He D
    Front Public Health; 2022; 10():840525. PubMed ID: 35273943
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Development of an Autophagy Score Signature for Predicting Overall Survival in Papillary Renal Cell Carcinoma.
    Gu X; Chen X; Zhu L; Song W; Wang A; Chu J; Wang T; Jiang P; Ge Y
    Dis Markers; 2020; 2020():8867019. PubMed ID: 33273989
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Identification of a set of Genes Improving Survival Prediction in kidney Renal Clear Cell Carcinoma through Integrative Reanalysis of Transcriptomic Data.
    Ruan B; Feng X; Chen X; Dong Z; Wang Q; Xu K; Tian J; Liu J; Chen Z; Shi W; Wang M; Qian L; Ding Q
    Dis Markers; 2020; 2020():8824717. PubMed ID: 33110456
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. What are the implications of using individual and combined sources of routinely collected data to identify and characterise incident site-specific cancers? a concordance and validation study using linked English electronic health records data.
    Strongman H; Williams R; Bhaskaran K
    BMJ Open; 2020 Aug; 10(8):e037719. PubMed ID: 32819994
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Profiles of overall survival-related gene expression-based risk signature and their prognostic implications in clear cell renal cell carcinoma.
    He Z; Deng T; Duan X; Zeng G
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32789468
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Data set for the Reporting of Carcinoma of the Renal Pelvis and Ureter-Nephroureterectomy and Ureterectomy Specimens: Recommendations From the International Collaboration on Cancer Reporting (ICCR).
    Samaratunga H; Judge M; Delahunt B; Srigley J; Brimo F; Comperat E; Koch M; Lopez-Beltran A; Reuter V; Shanks J; Tsuzuki T; van der Kwast T; Varma M; Grignon D
    Am J Surg Pathol; 2019 Oct; 43(10):e1-e12. PubMed ID: 31192862
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study.
    Wei JH; Feng ZH; Cao Y; Zhao HW; Chen ZH; Liao B; Wang Q; Han H; Zhang J; Xu YZ; Li B; Wu JT; Qu GM; Wang GP; Liu C; Xue W; Liu Q; Lu J; Li CX; Li PX; Zhang ZL; Yao HH; Pan YH; Chen WF; Xie D; Shi L; Gao ZL; Huang YR; Zhou FJ; Wang SG; Liu ZP; Chen W; Luo JH
    Lancet Oncol; 2019 Apr; 20(4):591-600. PubMed ID: 30880070
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Data set for the reporting of carcinoma of renal tubular origin: recommendations from the International Collaboration on Cancer Reporting (ICCR).
    Delahunt B; Srigley JR; Judge MJ; Amin MB; Billis A; Camparo P; Evans AJ; Fleming S; Griffiths DF; Lopez-Beltran A; Martignoni G; Moch H; Nacey JN; Zhou M
    Histopathology; 2019 Feb; 74(3):377-390. PubMed ID: 30325065
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
    Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
    Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Patterns of lymph node sampling and the impact of lymph node density in favorable histology Wilms tumor: An analysis of the national cancer database.
    Saltzman AF; Carrasco A; Amini A; Aldrink JH; Dasgupta R; Gow KW; Glick RD; Ehrlich PF; Cost NG
    J Pediatr Urol; 2018 Apr; 14(2):161.e1-161.e8. PubMed ID: 29133167
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma.
    Fabrizio FP; Costantini M; Copetti M; la Torre A; Sparaneo A; Fontana A; Poeta L; Gallucci M; Sentinelli S; Graziano P; Parente P; Pompeo V; De Salvo L; Simone G; Papalia R; Picardo F; Balsamo T; Flammia GP; Trombetta D; Pantalone A; Kok K; Paranita F; Muscarella LA; Fazio VM
    Oncotarget; 2017 Feb; 8(7):11187-11198. PubMed ID: 28061437
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Combined cell surface carbonic anhydrase 9 and CD147 antigens enable high-efficiency capture of circulating tumor cells in clear cell renal cell carcinoma patients.
    Liu S; Tian Z; Zhang L; Hou S; Hu S; Wu J; Jing Y; Sun H; Yu F; Zhao L; Wang R; Tseng HR; Zhau HE; Chung LW; Wu K; Wang H; Wu JB; Nie Y; Shao C
    Oncotarget; 2016 Sep; 7(37):59877-59891. PubMed ID: 27494883
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.